11-94464200-G-T
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_005591.4(MRE11):c.1138C>A(p.Arg380Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R380C) has been classified as Uncertain significance.
Frequency
Consequence
NM_005591.4 missense
Scores
Clinical Significance
Conservation
Publications
- ataxia-telangiectasia-like disorder 1Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, Ambry Genetics
- breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- prostate cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| MRE11 | NM_005591.4 | c.1138C>A | p.Arg380Ser | missense_variant | Exon 11 of 20 | ENST00000323929.8 | NP_005582.1 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| MRE11 | ENST00000323929.8 | c.1138C>A | p.Arg380Ser | missense_variant | Exon 11 of 20 | 1 | NM_005591.4 | ENSP00000325863.4 | ||
| MRE11 | ENST00000323977.7 | c.1138C>A | p.Arg380Ser | missense_variant | Exon 11 of 19 | 1 | ENSP00000326094.3 | |||
| MRE11 | ENST00000407439.7 | c.1147C>A | p.Arg383Ser | missense_variant | Exon 11 of 20 | 2 | ENSP00000385614.3 | |||
| MRE11 | ENST00000393241.8 | c.1138C>A | p.Arg380Ser | missense_variant | Exon 11 of 20 | 5 | ENSP00000376933.4 | 
Frequencies
GnomAD3 genomes  
GnomAD4 exome Cov.: 33 
GnomAD4 genome  
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome    Uncertain:1 
The p.R380S variant (also known as c.1138C>A), located in coding exon 10 of the MRE11A gene, results from a C to A substitution at nucleotide position 1138. The arginine at codon 380 is replaced by serine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Ataxia-telangiectasia-like disorder    Uncertain:1 
Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with MRE11-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with serine at codon 380 of the MRE11 protein (p.Arg380Ser). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and serine. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at